BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17852453)

  • 21. [Interaction of WAVE1 and genes involved in multiple drug resistance in children with acute myeloblastic leukemia].
    Yang MH; Zhao MY; He YL; Wang MH; Wang Z; Xie M; Wu XS; Cao LZ
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):175-9. PubMed ID: 20426950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disulfiram/copper complex activated JNK/c-jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells.
    Xu B; Shi P; Fombon IS; Zhang Y; Huang F; Wang W; Zhou S
    Blood Cells Mol Dis; 2011 Dec; 47(4):264-9. PubMed ID: 21911303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SIRT2 mediates multidrug resistance in acute myelogenous leukemia cells via ERK1/2 signaling pathway.
    Xu H; Li Y; Chen L; Wang C; Wang Q; Zhang H; Lin Y; Li Q; Pang T
    Int J Oncol; 2016 Feb; 48(2):613-23. PubMed ID: 26647771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines.
    Kostrzewa-Nowak D; Paine MJ; Wolf CR; Tarasiuk J
    Br J Cancer; 2005 Jul; 93(1):89-97. PubMed ID: 15942634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1.
    Zhou H; Ma H; Wei W; Ji D; Song X; Sun J; Zhang J; Jia L
    Cell Death Dis; 2013 Jun; 4(6):e654. PubMed ID: 23744354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells.
    Nadali F; Pourfathollah AA; Alimoghaddam K; Nikougoftar M; Rostami S; Dizaji A; Azizi E; Zomorodipour A; Ghavamzadeh A
    Hematology; 2007 Oct; 12(5):393-401. PubMed ID: 17852455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retaining cytotoxic activity of anthrapyridone CO1 against multidrug resistant cells is related to the ability to induce concomitantly apoptosis and lysosomal death of leukaemia HL60/VINC and HL60/DOX cells.
    Nowak R; Tarasiuk J
    J Pharm Pharmacol; 2013 Jun; 65(6):855-67. PubMed ID: 23647679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells.
    Misra R; Sahoo SK
    Mol Pharm; 2011 Jun; 8(3):852-66. PubMed ID: 21480667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia.
    Ma H; Zhou H; Song X; Shi S; Zhang J; Jia L
    Oncogene; 2015 Feb; 34(6):726-40. PubMed ID: 24531716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technetium-99m-tetrofosmin would be a substrate for multidrug resistance-associated protein (MRP): comparison between a leukemia cell line with high MRP gene expression and its parental cell line.
    Li XF; Kinuya S; Yokoyama K; Konishi S; Ma YY; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Cancer Biother Radiopharm; 2001 Feb; 16(1):17-23. PubMed ID: 11279794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Xu HB; Li L; Liu GQ
    Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
    Zaja R; Caminada D; Loncar J; Fent K; Smital T
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):207-18. PubMed ID: 18076962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The causes of treatment ineffectiveness in acute myelogenous leukemia--the role of blast resistance to cytotoxic drugs].
    Machaczka M; Rucińska M; Jabłoński M; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):407-13. PubMed ID: 10021886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo.
    Bouvy C; Wannez A; Laloy J; Chatelain C; Dogné JM
    Leuk Res; 2017 Nov; 62():70-76. PubMed ID: 28987820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells.
    Zhou Q; Chen Y; Zhang L; Zhong Y; Zhang Z; Wang R; Jin M; Gong M; Qiu Y; Kong D
    Oncotarget; 2017 Jun; 8(24):39064-39076. PubMed ID: 28388564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells.
    Cui XY; Skretting G; Jing Y; Sun H; Sandset PM; Sun L
    Blood Cells Mol Dis; 2013 Oct; 51(3):177-84. PubMed ID: 23725749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
    Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
    Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy.
    Månsson E; Paul A; Löfgren C; Ullberg K; Paul C; Eriksson S; Albertioni F
    Br J Haematol; 2001 Sep; 114(3):557-65. PubMed ID: 11552980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.